Huadong Medicine Co., Ltd (SHE:000963)

Market Cap	70.62B
Revenue (ttm)	43.09B
Net Income (ttm)	3.70B
Shares Out	1.75B
EPS (ttm)	2.11
PE Ratio	19.17
Forward PE	19.38
Dividend	0.93 (2.30%)
Ex-Dividend Date	Sep 18, 2025

Volume	8,918,080
Average Volume	9,159,632
Open	43.42
Previous Close	41.17
Day's Range	39.87 - 43.42
52-Week Range	30.95 - 47.36
Beta	0.42
RSI	41.91
Earnings Date	Oct 28, 2025

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 18,265
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2024, Huadong Medicine's revenue was 41.91 billion, an increase of 3.16% compared to the previous year's 40.62 billion. Earnings were 3.51 billion, an increase of 23.72%.